In last trading session, Lineage Cell Therapeutics Inc (AMEX:LCTX) saw 0.76 million shares changing hands with its beta currently measuring 1.27. Company’s recent per share price level of $0.68 trading at -$0.01 or -2.52% at ring of the bell on the day assigns it a market valuation of $149.00M. That closing price of LCTX’s stock is at a discount of -136.76% from its 52-week high price of $1.61 and is indicating a premium of 29.41% from its 52-week low price of $0.48.
Lineage Cell Therapeutics Inc (AMEX:LCTX) trade information
Upright in the red during last session for losing -2.52%, in the last five days LCTX remained trading in the red while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $0.68 price level, adding 9.32% to its value on the day. Lineage Cell Therapeutics Inc’s shares saw a change of 34.53% in year-to-date performance and have moved -1.31% in past 5-day. Lineage Cell Therapeutics Inc (AMEX:LCTX) showed a performance of 0.15% in past 30-days.
Lineage Cell Therapeutics Inc (LCTX) estimates and forecasts
This year revenue growth is estimated to fall -7.73% from the last financial year’s standing.
6 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 1.62M for the same. And 3 analysts are in estimates of company making revenue of 1.36M in the next quarter. Company posted 2.12M and 1.44M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 19.25% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 8.33% while estimates for its earnings growth in next 5 years are of 9.14%.
Lineage Cell Therapeutics Inc (AMEX:LCTX)’s Major holders
BROADWOOD CAPITAL INC is the top institutional holder at LCTX for having 41.67 million shares of worth $41.55 million. And as of 2024-06-30, it was holding 22.0675 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 9.56 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.2264 of outstanding shares, having a total worth of $9.53 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 4.42 shares of worth $2.99 million or 2.00% of the total outstanding shares. The later fund manager was in possession of 4.0 shares on Nov 30, 2024 , making its stake of worth around $2.7 million in the company or a holder of 1.81% of company’s stock.
